Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2009-09-03

Clinical Trial Update: Proteomic Study of Urinary Stone Disease

View source ↗

Summary

Completed proteomic study of urinary stone disease (urolithiasis) and related hyperoxaluria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Urinary Calculi, Hyperoxaluria | Status: COMPLETED